Abstract:Elevated blood glucose levels contribute to a series of complications in patients with diabetes mellitus, including chronic ulcers and accelerated atherosclerosis. Dysregulated endothelial migration induced by high glucose is important in vascular-associated complications. In the present study, cluster of differentiation (CD)97/adhesion G protein-coupled receptor 5 (ADGRE5), a member of the G protein-coupled receptor protein family, stimulated angiogenesis was investigated to determine its role in cell models of diabetes mellitus using lentivirus-mediated overexpression and siRNA transfection. The results revealed reduced expression in high glucose-treated human umbilical vein endothelial cells and in the endothelium of diabetic mice. Among the three CD97 isoforms, the majority of the expression of CD97 (EGF1,2,5) in the endothelial cells was regulated by high levels of glucose. Using stable lentivirus-mediated transfection and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, the present study constructed CD97-overexpression and CD97-knockout endothelial cell lines. Migration assays showed that the lentivirus-mediated overexpression of CD97/ADGRE5 improved the inhibition of high glucose-induced endothelial cell migration. In addition, using cytoskeleton staining, it was found that CD97 promoted membrane ruffling and lamellipodia formation. Cell division cycle 42, a small GTP-binding protein, and its downstream factor, actin-related protein 2, were involved in CD97-induced actin reorganization in endothelial cells. Additionally, the use of transcription factor filter plate assays revealed that the nuclear translocation of signal transducer and activator of transcription 1 stimulated by high glucose contributed to the inhibited transcription of CD97. In conclusion, the present study established that the overexpression of CD97 improved high glucose-induced dysfunction of endothelial cell migration. These findings provide insight to assist in identifying therapeutic targets with potential to ameliorate certain vascular complications of diabetes.

Resveratrol Attenuates High Glucose-Induced Vascular Endothelial Cell Injury by Activating the E2F3 Pathway

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

Effects of resveratrol on the Nrf 2 and HO-1 expression in diabetic vascular endothelial cells

Lentivirus-mediated Overexpression of CD97/ADGRE5 Reverses Dysregulated High Glucose-Induced Endothelial Cell Migration

Resveratrol protects mesangial cells under high glucose by regulating the miR-1231/IGF1/ERK pathway

Effect of resveratrol derivative BTM-0512 on high glucose-induced dysfunction of endothelial cells: role of SIRT1.

Resveratrol Prevents Ros-Induced Apoptosis In High Glucose-Treated Retinal Capillary Endothelial Cells Via The Activation Of Ampk/Sirt1/Pgc-1 Alpha Pathway

The protective role of resveratrol against high glucose-induced oxidative stress and apoptosis in HepG2 cells

Critical Effect of Vegf in the Process of Endothelial Cell Apoptosis Induced by High Glucose

Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity.

High-glucose treatment regulates biological functions of human umbilical vein endothelial cells via Sirt1/FOXO3 pathway

High-glucose Induced HIF-1α Down-Regulation Impairs the Function of the Endothelial Progenitor Cells Via PI3K/AKT Signaling Pathway

Upregulation of Connexin 43 and Apoptosis-Associated Protein Expression by High Glucose in H9c2 Cells Was Improved by Resveratrol Via the Autophagy Signaling Pathway

Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.

Resveratrol Inhibits High Glucose-Induced Activation of AP-1 and NF-κB Via SphK1/S1P2 Pathway to Attenuate Mesangial Cells Proliferation and Inflammation

Survivin Regulated by Autophagy Mediates Hyperglycemia-Induced Vascular Endothelial Cell Dysfunction.

Resveratrol Attenuates Early Diabetic Nephropathy by Down-Regulating Glutathione S-Transferases Mu in Diabetic Rats

High Glucose Induces Renal Mesangial Cell Proliferation and Fibronectin Expression Through JNK/NF-κB/NADPH Oxidase/ros Pathway, Which is Inhibited by Resveratrol

Inhibitory Effect of Resveratrol on Advanced Glycation End Products-Induced Mesangial Cell Proliferation

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis.